Recombinant Supella longipalpa Periviscerokinin-3

What is Periviscerokinin-3 from Supella longipalpa?

Periviscerokinin-3 (PVK-3) from Supella longipalpa (the brown-banded cockroach) is a neuropeptide belonging to the periviscerokinin family. It has the sequence GSSGMIPFPRV-NH₂ and was identified from abdominal perisympathetic organs (PSOs) of blaberoid cockroaches . PSOs serve as major storage and release centers for neurohormones produced in the ventral nerve cord. The periviscerokinin family is characterized by a highly conserved N-terminus (GSSG), while at the C-terminus, only the penultimate amino acid residue (Arg) is consistently present across all family members . These neuropeptides function as myoactive peptides in cockroaches and are part of the larger neuropeptide family that regulates processes such as homeostasis, development, reproduction, and behavior .

How does Periviscerokinin-3 differ structurally from other periviscerokinins?

Periviscerokinin-3 belongs to a family that includes multiple related peptides. Research has identified three novel periviscerokinins from blaberoid cockroaches:

All three periviscerokinins share the conserved N-terminal GSSG sequence and the penultimate arginine (R) residue, which are characteristic of the periviscerokinin family . The variations in the middle segment of the peptides likely contribute to their specific receptor interactions and physiological functions.

How was Periviscerokinin-3 initially identified and characterized?

Periviscerokinin-3 was identified directly from extracts of single abdominal perisympathetic organs of blaberoid cockroaches using a combination of sophisticated analytical techniques. Researchers employed electrospray ionization-quadrupole time of flight (ESI-QTOF) mass spectrometry (MS) for initial detection and characterization . The sequence was subsequently confirmed using Edman degradation, which involves sequentially cleaving amino acids from the N-terminus of the peptide . This dual analytical approach allowed researchers to conclusively establish the primary structure of PVK-3 even from the minuscule PSOs, which are only 70-90 μm in diameter. The screening of extracts from five different species of the suborder Blaberoidea revealed that they all contain the same three novel periviscerokinins .

What challenges exist in producing recombinant Supella longipalpa Periviscerokinin-3?

Producing recombinant PVK-3 presents several technical challenges that researchers must address:

• Post-translational modifications: The C-terminal amidation (-NH₂) is crucial for the biological activity of most neuropeptides but is difficult to achieve in standard recombinant systems without specific enzymatic processing.

• Oxidative stability: The methionine residue (M) in position 5 of the sequence GSSGMIPFPRV-NH₂ is particularly susceptible to oxidation. Research on similar neuropeptides has identified oxidation products as natural variants that may affect biological activity . This susceptibility necessitates careful handling to prevent artificial oxidation during recombinant production.

• Size constraints: At only 11 amino acids, PVK-3 is too small for efficient direct expression in most recombinant systems, necessitating fusion protein strategies or chemical synthesis approaches.

• Purification challenges: Separating the small peptide from contaminants or fusion partners while maintaining its integrity requires optimized chromatographic techniques.

• Structural validation: Ensuring that the recombinant peptide adopts the same secondary structure as the native form is essential for functional studies and requires sophisticated analytical methods including those used in the original characterization .

How can researchers differentiate between naturally occurring oxidation products and artifacts in PVK-3 preparations?

Distinguishing natural oxidation variants from artifacts requires a methodical analytical approach:

• Fresh tissue analysis: Analysis of freshly dissected tissues with precautions taken against oxidation can establish the natural state of the peptide. Similar approaches have been used for studying oxidation products in other insect neuropeptides .

• Ex vivo release studies: Measuring peptides released from tissues upon stimulation with depolarizing saline can confirm which forms are physiologically relevant, similar to methods described for cockroach corpus cardiacum preparations .

• Comparative MS analysis: High-resolution mass spectrometry can detect mass shifts indicative of oxidation (+16 Da for single oxidation) and determine their location through fragmentation patterns.

• Quantitative assessment: The ratio of oxidized to non-oxidized forms in fresh tissue samples compared to recombinant preparations can help establish physiological relevance. Research on other insect neuropeptides suggests that oxidized forms typically comprise less than 7% of the total peptide in natural samples .

• Functional testing: Bioassays comparing the activity of oxidized and non-oxidized forms can reveal whether oxidation affects biological function, providing insight into whether oxidized variants are functional or degradation products.

What molecular mechanisms might explain the tissue-specific distribution of Periviscerokinin-3 in Supella longipalpa?

The restricted distribution of PVK-3 in abdominal perisympathetic organs and its absence from the retrocerebral complex likely involves several regulatory mechanisms:

• Tissue-specific gene expression: The precursor genes for PVK-3 may be selectively expressed in neurons that project to abdominal PSOs.

• Differential processing of precursors: The precursor protein may undergo tissue-specific post-translational processing. This could be related to the distribution of processing enzymes across different neurohaemal organs.

• Evolutionary specialization: The specific distribution may reflect evolutionary adaptation for localized control of functions in the abdominal region of the insect. This tissue specificity might be associated with the physiological needs of blaberoid cockroaches.

• Microbiome influences: The gut microbiome of S. longipalpa, which shows developmental stage-specific composition dominated by Lactobacillus and Akkermansia , may indirectly influence neuropeptide distribution through signaling pathways.

• Endosymbiont interactions: The presence of endosymbionts like Blattabacterium and Wolbachia in S. longipalpa might affect neuropeptide distribution through evolutionary co-adaptation mechanisms.

What expression systems are most suitable for producing recombinant Supella longipalpa Periviscerokinin-3?

The choice of expression system for recombinant PVK-3 production depends on research requirements:

For optimal results, researchers should consider:

• Using a dual approach of recombinant production for the peptide backbone and subsequent enzymatic amidation

• Including purification tags that can be removed without leaving additional residues

• Screening multiple systems in parallel for yield and quality optimization

How can researchers verify the structural integrity of recombinant Periviscerokinin-3?

Comprehensive structural verification requires multiple complementary techniques:

• Primary structure verification:

  • ESI-QTOF MS and MS/MS fragmentation for sequence confirmation

  • Edman degradation for N-terminal sequence verification

  • Amino acid analysis after acid hydrolysis for composition confirmation

• C-terminal amidation confirmation:

  • High-resolution MS to distinguish between carboxyl and amide C-terminus

  • Chemical derivatization approaches specific for C-terminal functional groups

  • Enzymatic methods using carboxypeptidases

• Secondary structure analysis:

  • Circular dichroism (CD) spectroscopy

  • Nuclear magnetic resonance (NMR) for solution structure

  • Fourier-transform infrared spectroscopy (FTIR) for secondary structure elements

• Oxidation status assessment:

  • Liquid chromatography coupled to high-resolution mass spectrometry (LC-MS) for detecting oxidized variants

  • Multiple reaction monitoring (MRM) for quantification of oxidized vs. non-oxidized forms

• Functional verification:

  • Bioassays comparing recombinant peptide activity with synthetic standards

  • Receptor binding assays using membrane preparations from tissues known to respond to PVK-3

What purification strategies maximize yield and maintain integrity of recombinant Periviscerokinin-3?

Efficient purification of recombinant PVK-3 requires a strategic approach:

• Initial capture:

  • For fusion proteins: Immobilized metal affinity chromatography (IMAC) for His-tagged constructs

  • For secreted peptides: Ion exchange chromatography based on the peptide's theoretical pI (~11.0)

  • Potential for immunoaffinity approaches using antibodies against the conserved N-terminal region

• Release from fusion partners:

  • Enzymatic cleavage using proteases with high specificity (e.g., TEV protease)

  • Careful monitoring of cleavage using SDS-PAGE similar to methods used for protein concentration determination in cockroach extract studies

  • Optimized cleavage conditions to minimize oxidation of the methionine residue

• Final purification:

  • Reversed-phase HPLC using C18 columns with shallow acetonitrile gradients

  • Monitoring multiple wavelengths (214, 254, and 280 nm) for detection

  • Collection and pooling of fractions based on analytical assessment

• Quality control:

  • Bradford assay for protein concentration determination

  • High-resolution MS for identity confirmation

  • Analytical HPLC for purity assessment (>95% recommended for functional studies)

  • Stability testing under various storage conditions (lyophilized vs. solution, temperature effects)

How should bioassays be designed to evaluate the biological activity of recombinant Periviscerokinin-3?

Robust bioassay design for recombinant PVK-3 requires careful consideration of physiological relevance:

• Myoactivity assays:

  • Isolated visceral muscle preparations from S. longipalpa

  • Force transducer measurements of contraction/relaxation responses

  • Concentration-response curves (10⁻¹² to 10⁻⁶ M range)

  • Comparison with other periviscerokinins (PVK-1, PVK-2) to establish relative potency

• Ex vivo neurohaemal organ preparations:

  • Intact perisympathetic organs in physiological saline

  • Application of depolarizing stimuli to trigger endogenous peptide release

  • Comparison of release patterns with exogenous application of recombinant peptide

  • Combined electrophysiological and peptide release measurements

• In vivo studies:

  • Microinjection of recombinant PVK-3 into different developmental stages

  • Monitoring physiological parameters (heart rate, gut motility)

  • Behavioral observations following administration

  • Consideration of developmental stage-specific effects, given the differences observed in nymphal gut microbiome diversity

• Controls and standards:

  • Synthetic PVK-3 as reference standard

  • Scrambled sequence peptide as negative control

  • Heat-inactivated peptide preparations

  • Vehicle controls for all test conditions

How can researchers investigate potential interactions between Periviscerokinin-3 and the microbiome of Supella longipalpa?

Exploring PVK-3-microbiome interactions requires integrative experimental approaches:

• Correlation analyses:

  • Measure PVK-3 expression levels across developmental stages

  • Simultaneously characterize microbiome composition using 16S rRNA gene amplicon sequencing, similar to methods used to identify dominant bacterial taxa like Lactobacillus and Akkermansia in S. longipalpa

  • Analyze potential correlations between peptide levels and bacterial community composition

  • Examine whether the negative correlations observed between Blattabacterium and the gut microbiome extend to neuropeptide systems

• Experimental manipulations:

  • Administer recombinant PVK-3 to cockroaches and assess microbiome changes

  • Manipulate the microbiome using antibiotics and monitor effects on PVK-3 expression

  • Specifically examine effects on dominant genera like Lactobacillus and Akkermansia

  • Compare early and late instar nymphs, which show significant differences in gut microbiome alpha diversity

• Mechanistic investigations:

  • Determine whether PVK-3 affects gut physiological parameters that influence microbiota

  • Test if microbial metabolites regulate PVK-3 production or release

  • Explore whether endosymbionts like Wolbachia, which colonizes S. longipalpa at high prevalence , influence neuropeptide signaling

• Developmental perspective:

  • Compare findings across developmental stages, focusing on transitions between early and late instar nymphs

  • Address whether the significant increase in gut microbiome diversity observed in late nymphs correlates with changes in neuropeptide expression

What approaches can help resolve contradictory data in Periviscerokinin-3 activity studies?

When confronted with conflicting results in PVK-3 research, systematic troubleshooting is essential:

• Peptide quality assessment:

  • Verify sequence integrity and purity of different peptide preparations

  • Check for oxidation products, particularly of the methionine (M) in GSSGMIPFPRV-NH₂

  • Confirm C-terminal amidation status

  • Perform side-by-side comparisons of different peptide sources using SDS-PAGE and Western blot techniques similar to those used in immunological studies of cockroach proteins

• Experimental standardization:

  • Establish standard operating procedures for bioassays

  • Control for tissue source, age, and preparation methods

  • Define precise buffer compositions, pH, and temperature conditions

  • Standardize data collection methods and analysis parameters

• Biological variability considerations:

  • Account for developmental stage effects (different responses in early vs. late nymphs)

  • Consider sex differences (male vs. female cockroaches)

  • Examine potential microbial influences, given the significant effect of nymphal development on diversity and variation in the gut microbiome

• Statistical remediation:

  • Increase sample sizes based on power analysis

  • Employ appropriate statistical tests for the data distribution

  • Use hierarchical analysis approaches for nested experimental designs

  • Conduct meta-analysis when multiple independent studies are available

How do structural modifications affect the biological activity of Periviscerokinin-3?

Understanding structure-activity relationships for PVK-3 requires systematic analysis:

When analyzing these modifications, researchers should:

• Test multiple concentrations spanning at least 5 orders of magnitude

• Use multiple bioassay systems to detect activity shifts

• Compare EC₅₀ values and maximum efficacy

• Consider potential species-specific differences in receptor interactions

What molecular modeling approaches are most informative for studying Periviscerokinin-3 receptor interactions?

Computational methods can provide valuable insights into PVK-3 receptor binding:

• Peptide structure prediction:

  • Ab initio modeling for the small peptide

  • NMR-constrained modeling if experimental data are available

  • Assessment of conformational flexibility through molecular dynamics simulations

  • Analysis of potential secondary structure elements

• Receptor homology modeling:

  • Based on related G-protein coupled receptors with known structures

  • Refinement using molecular dynamics simulations

  • Validation through experimental mutagenesis data

  • Integration of species-specific sequence variations

• Docking simulations:

  • Flexible docking to account for peptide conformational changes upon binding

  • Identification of key binding pocket residues

  • Energetic analysis of peptide-receptor interactions

  • Comparison with related periviscerokinins to identify selectivity determinants

• Virtual screening applications:

  • Design of peptide mimetics based on essential pharmacophore features

  • Screening of small molecule libraries for potential antagonists

  • Prediction of modifications that might enhance stability without compromising activity

What is the significance of the conserved elements in the Periviscerokinin-3 sequence?

The conservation pattern in PVK-3 and related peptides reveals evolutionary and functional insights:

• N-terminal GSSG motif:

  • Highly conserved across periviscerokinins from different cockroach species

  • Likely involved in initial receptor recognition

  • May interact with an evolutionarily conserved binding pocket region

  • Essential for maintaining correct peptide orientation during receptor binding

• Central hydrophobic region:

  • Variable across different periviscerokinins (MIPF in PVK-3)

  • May contribute to receptor subtype selectivity

  • Provides conformational flexibility for optimal receptor interaction

  • Contains the oxidation-susceptible methionine that could serve as a regulatory mechanism

• C-terminal PRV-NH₂:

  • Conserved penultimate arginine across all family members

  • Critical for high-affinity receptor binding

  • Amidation essential for full biological activity

  • Terminal valine may contribute to receptor subtype selectivity

• Evolutionary significance:

  • Conservation across five different species of the suborder Blaberoidea suggests functional importance

  • Variations in non-conserved regions may reflect species-specific adaptations

  • Presence in abdominal PSOs but absence in retrocerebral complex indicates tissue-specific functional specialization

How might new technologies advance our understanding of Periviscerokinin-3 function?

Emerging technologies offer promising avenues for PVK-3 research:

• Single-cell transcriptomics:

  • Identification of cells expressing PVK-3 precursors

  • Characterization of receptor expression patterns

  • Mapping of signaling networks in target tissues

  • Discovery of co-expressed neuropeptides or modulators

• CRISPR-based approaches:

  • Generation of PVK-3 knockout or knockdown cockroach lines

  • Creation of receptor mutants to study binding requirements

  • Introduction of tagged versions for in vivo tracking

  • Precise modification of sequence elements to test functional hypotheses

• Advanced imaging techniques:

  • In vivo calcium imaging to visualize signaling in real-time

  • Super-resolution microscopy of peptide localization

  • Whole-animal functional imaging during peptide administration

  • Correlative light and electron microscopy for subcellular context

• Integrative multi-omics:

  • Combined proteomics, metabolomics, and microbiome analysis

  • Systems biology approaches to model neuropeptide-microbiome interactions

  • Integration with developmental transcriptomics

  • Comparison between S. longipalpa and other cockroach species like B. germanica

How can Periviscerokinin-3 research contribute to comparative neuroendocrinology?

PVK-3 research offers valuable comparative insights:

• Evolutionary perspectives:

  • Comparison of periviscerokinin systems across diverse cockroach species

  • Investigation of related peptides in other insect orders

  • Reconstruction of the evolutionary history of this neuropeptide family

  • Correlation with habitat specialization and physiological adaptations

• Adaptation to the indoor biome:

  • Comparison between S. longipalpa and other indoor-adapted species like B. germanica

  • Investigation of potential roles in physiological adaptations to human-built environments

  • Assessment of links between neuropeptide signaling and the specialized microbiome of indoor-adapted species

• Convergent evolution analysis:

  • Identification of functionally similar peptides in distantly related arthropods

  • Comparison with mammalian peptides that serve analogous functions

  • Investigation of receptor evolution and potential cross-reactivity

  • Development of evolutionary models for peptide-receptor co-adaptation

• Endosymbiont influences:

  • Investigation of how the presence of both Wolbachia and Blattabacterium in S. longipalpa affects neuropeptide evolution

  • Comparison with species harboring different endosymbiont combinations

  • Exploration of possible horizontal gene transfer events affecting neuropeptide systems

What interdisciplinary approaches could enhance Periviscerokinin-3 research impact?

Cross-disciplinary integration can significantly advance PVK-3 research:

• Synthetic biology integration:

  • Creation of engineered cells that report on PVK-3 activity

  • Development of biocontainment strategies for field applications

  • Design of synthetic circuits responsive to neuropeptide signaling

  • Construction of minimal systems to study essential signaling components

• Material science applications:

  • Development of peptide-based biomaterials with environmental sensing capabilities

  • Creation of biodegradable delivery systems for peptide administration

  • Design of self-assembling nanostructures based on peptide properties

  • Integration with wearable sensors for pest detection

• Computational biology synergies:

  • Machine learning approaches to predict structure-activity relationships

  • Network modeling of neuropeptide-microbiome-endosymbiont interactions

  • Simulation of evolutionary scenarios for peptide family diversification

  • Development of predictive models for peptide stability and bioactivity

• Urban ecology connections:

  • Integration of PVK-3 research with broader studies of indoor biome adaptation

  • Investigation of how built environment parameters affect neuropeptide systems

  • Application to integrated pest management strategies for indoor environments

  • Assessment of potential effects of climate change on neuropeptide signaling in urban pests